One moment, your dog is fine. Next, they are on the floor.
Legs trembling. Eyes unfocused. Body seizing without any warning, you could have acted on.
You rush them to the vet, terrified. The blood work comes back, and the glucose level is dangerously low. But your dog has not skipped a meal. They have not been given any medication that could cause this. Nothing in your routine changed.
What happened?
In some dogs, the answer is insulinoma. A tumor growing silently in the pancreas, producing insulin around the clock, driving blood sugar down to levels the brain and body cannot sustain.
It is a frightening diagnosis. It is also one that, when understood clearly, can be managed with real intention and with outcomes that matter.
This guide explains everything you need to know about insulinoma in dogs, from the biology of how it works to the treatment decisions that follow a confirmed diagnosis.
What Is Insulinoma in Dogs?
Insulinoma is a neuroendocrine tumor that originates from the beta cells of the pancreas.
To understand why this matters, you need to understand what beta cells do. In a healthy dog, beta cells monitor blood glucose levels continuously and respond by releasing precise amounts of insulin to bring glucose into cells when levels rise. It is a tightly regulated process. The body produces insulin when it is needed and stops when it is not.
Insulinoma breaks that regulation completely.
The tumor cells, being cancerous, do not respond to the normal feedback signals that tell healthy beta cells when to stop producing insulin. They secrete insulin continuously, regardless of what the blood glucose level is. Even when blood sugar has dropped to dangerously low levels, the tumor keeps releasing more insulin, driving it lower still.
The result is persistent, uncontrolled hypoglycemia. And hypoglycemia, when severe, is a medical emergency.
Most canine insulinomas are malignant. This is one of the important early facts for any owner to absorb. Unlike some other pancreatic conditions, insulinoma is not typically benign. By the time the diagnosis is confirmed, the majority of affected dogs already have metastatic spread to the regional lymph nodes, liver, or, in some cases, the lungs. This shapes the prognosis and the treatment approach in significant ways.
How Insulinoma Affects Dogs
The Role of Insulin and Glucose
In a healthy body, insulin and glucose exist in a carefully balanced relationship. After a meal, blood glucose rises, and insulin is released to facilitate the uptake of that glucose into cells across the body, particularly muscle and fat tissue. Blood glucose returns to normal. Insulin production slows. Balance is restored.
The brain is uniquely dependent on this system because it cannot store glucose. It relies on a continuous supply from the bloodstream to power every function, from basic physiological regulation to conscious awareness. Without adequate glucose reaching the brain, neurological function degrades rapidly.
Effects of Low Blood Sugar
When insulinoma drives blood glucose persistently low, the brain is the first organ to suffer.
Initial effects include mild confusion, disorientation, and muscle weakness as the brain begins to run short of its primary fuel. As glucose drops further, the neurological effects become more severe. Tremors, muscle twitching, loss of coordination, and seizures follow as the brain loses its ability to function normally.
At critically low glucose levels, the dog may lose consciousness entirely. Prolonged severe hypoglycemia causes irreversible neurological damage and, if untreated, death.
This explains the clinical picture that many owners describe: sudden episodes of apparent seizure or collapse that come and go unpredictably, often triggered by exercise, excitement, or simply the extended time between meals when glucose is not being replenished from digestion.
Symptoms of Insulinoma in Dogs
One of the most unsettling aspects of insulinoma is that the symptoms are episodic. Your dog may appear completely normal between hypoglycaemic events, which makes it easy to dismiss early episodes as isolated incidents, a stumble, an off day, a brief moment of unusual fatigue.
Do not dismiss them. The pattern is the signal.
Early Warning Signs
Early symptoms of insulinoma reflect mild to moderate hypoglycemia and are easy to attribute to other causes. They tend to occur intermittently, often in the morning before a meal, after exercise, or during periods of excitement when glucose is being consumed more rapidly.
Early signs include:
- Sudden episodes of weakness or unsteadiness, particularly in the hind limbs
- Unusual lethargy or a glazed, confused expression that resolves on its own
- Trembling or fine muscle tremors that come and go
- Reduced stamina during walks or play, with the dog appearing to suddenly run out of energy
- Brief episodes of wobbling or loss of balance that the dog recovers from within minutes
- Increased appetite or food-seeking behaviour as the body tries to compensate for low glucose
- Occasional vomiting without an obvious dietary cause
If you notice these signs, particularly if they recur over days or weeks, this warrants a prompt veterinary visit. Documenting the timing, duration, and circumstances of each episode, including whether it occurred before or after a meal or following exercise, is genuinely useful information for your vet.
Severe Symptoms
As insulinoma progresses or during a severe acute hypoglycaemic episode, the symptoms escalate rapidly and become a veterinary emergency.
Severe symptoms include:
- Tonic-clonic seizures or focal seizure activity
- Complete collapse with inability to stand
- Profound muscle weakness and inability to move limbs purposefully
- Disorientation or apparent blindness
- Pale or white gums indicating poor peripheral circulation
- Muscle twitching or paddling movements during a postictal episode
- Loss of consciousness or unresponsiveness
- Status epilepticus, meaning prolonged or repeated seizures without recovery between events
If your dog is actively seizing or has collapsed and cannot be roused, this is a medical emergency. Do not attempt to administer food or anything by mouth to a dog that is unconscious or actively seizing. Get to an emergency veterinary facility immediately.
Related Videos
Causes of Insulinoma in Dogs
The exact cellular trigger that causes pancreatic beta cells to begin proliferating abnormally in insulinoma is not fully understood. As with many canine cancers, the definitive answer of why it happens in any specific dog is not always available.
What is known is the process: normal beta cells undergo a mutation or series of mutations that disrupt the regulatory pathways controlling cell division and insulin secretion, producing a tumor that grows and functions autonomously.
Breed Predisposition
Insulinoma is not equally distributed across all breeds and body types.
Larger and medium-to-large breeds appear to be over-represented among diagnosed dogs. Breeds with a documented higher incidence include:
- German Shepherds
- Irish Setters
- Labrador Retrievers
- Boxers
- Golden Retrievers
- Standard Poodles
- Fox Terriers
This does not mean small breeds are immune. Insulinoma can develop in any dog. But if you own a large breed dog entering their senior years and you notice the episodic weakness or collapse pattern described above, insulinoma should be on the list of possibilities to investigate.
Age and Other Risk Factors
Insulinoma is predominantly a disease of middle-aged to older dogs. The average age at diagnosis is approximately nine to ten years, though cases have been documented in dogs as young as three.
There is no confirmed hormonal, dietary, or environmental risk factor that has been clearly established as a cause of insulinoma in dogs. It appears to develop spontaneously in susceptible individuals, shaped primarily by genetic predisposition and the cumulative cellular changes of aging.
Diagnosing Insulinoma in Dogs
Diagnosing insulinoma requires demonstrating a specific and diagnostically significant pattern in the blood: a low blood glucose level occurring simultaneously with an inappropriately elevated or normal insulin level.
In a healthy dog experiencing low blood sugar, the pancreas should suppress insulin production to near zero. A dog with insulinoma maintains elevated insulin even as glucose falls. That failure of appropriate suppression is the biochemical fingerprint of the disease.
Blood Glucose and Insulin Tests
The initial step is blood glucose measurement. In a dog presenting with episodic weakness, collapse, or seizures, blood glucose is checked immediately. A value below 60 mg/dL, particularly in the context of relevant clinical signs, raises a strong suspicion for insulinoma.
However, blood glucose alone is not diagnostic because many conditions can cause hypoglycemia. The key test is the simultaneous measurement of blood insulin at the same time the glucose is low.
This produces what is called the amended insulin-to-glucose ratio. In a normal dog with low blood sugar, insulin is suppressed. In a dog with insulinoma, insulin remains elevated or inappropriately normal relative to the glucose level. This pattern is highly suggestive of a functional insulin-secreting tumor.
Some dogs require a supervised fasting test, meaning a period of food restriction under veterinary observation with serial glucose monitoring, to capture a spontaneous hypoglycaemic episode during which the insulin measurement can be taken. This test carries risk and is only performed in an appropriate clinical setting with immediate treatment available.
Imaging and Staging
Once the biochemical diagnosis is established, imaging is used to identify the tumor and assess the extent of disease.
Abdominal ultrasound is the first-line imaging modality. Pancreatic insulinomas may be visible on ultrasound as discrete nodules within the pancreatic tissue, though small tumors can be missed because of their size and the pancreas’s anatomical location. The liver, regional lymph nodes, and spleen are also evaluated for metastatic lesions.
CT scanning provides superior anatomical detail and is the preferred staging tool when available. It allows the surgical team to identify the tumor’s precise location within the pancreas and map any spread to surrounding structures before making a surgical plan.
Chest X-rays are performed to evaluate the lungs for metastatic disease, which is less common than hepatic or lymph node spread but can occur in advanced cases.
The staging information gathered from imaging is critical because it directly informs the treatment decision. A dog with disease confined to the pancreas has a fundamentally different surgical picture than one with confirmed hepatic metastases.
Treatment for Insulinoma in Dogs
Treatment for insulinoma has two parallel objectives: controlling the life-threatening hypoglycemia in the immediate term, and addressing the tumor itself for longer-term disease management.
These objectives are not always equally achievable, and the balance between them depends on the extent of disease at the time of diagnosis.
Surgical Removal
Surgery is the primary treatment for insulinoma and offers the best chance of disease control and meaningful extension of a good-quality life.
The standard procedure is a partial pancreatectomy, the surgical removal of the portion of the pancreas containing the tumor. If a discrete tumor nodule is identified, it may be excised individually. The goal is to remove as much of the functional tumor mass as possible.
Surgery provides several benefits. It removes the primary source of unregulated insulin production, reduces or eliminates the frequency and severity of hypoglycaemic episodes, provides tissue for histopathological confirmation of the diagnosis, and allows direct intraoperative assessment of the liver and lymph nodes for metastatic spread.
The surgical risks include post-operative pancreatitis, hypoglycemia in the immediate post-operative period if residual tumor tissue remains, and paradoxical hyperglycemia, meaning high blood sugar, if enough insulin-producing tissue is removed that the dog becomes transiently diabetic.
Post-operative monitoring of blood glucose is intensive and requires hospitalisation for at least several days following surgery.
In dogs where surgery achieves complete visible disease removal, median survival times are meaningfully longer than in dogs managed with medication alone. Even in dogs with confirmed metastatic disease, debulking surgery, removing the primary tumor even when spread is present, can significantly improve glucose control and quality of life.
Medical Management
Not all dogs with insulinoma are surgical candidates. Advanced age, significant concurrent disease, confirmed widespread metastasis, or owner preference may make surgery inappropriate or undesirable. In these cases, medical management becomes the primary strategy.
Medical management focuses on stabilising blood glucose and reducing the frequency and severity of hypoglycaemic episodes.
Key components include:
Dietary modification is central. Small, frequent meals throughout the day, typically three to six meals rather than one or two, help maintain steadier blood glucose levels by providing a consistent supply of nutrients. Simple sugars and high-carbohydrate foods are avoided because they cause rapid glucose spikes followed by exaggerated insulin responses from the tumor. Complex carbohydrates and protein-rich foods that release glucose more slowly are preferred.
Prednisolone is commonly used in medical management. It stimulates glucose production by the liver and reduces cellular glucose uptake, counteracting the effects of excessive insulin. Starting doses are typically low and adjusted based on response.
Diazoxide is a medication that directly inhibits insulin secretion from beta cells, including tumor cells. It can be effective in reducing hypoglycaemic episodes in dogs that respond to it. It is used when prednisolone alone is insufficient.
Emergency glucose supplementation at home, in the form of corn syrup or a glucose gel rubbed onto the gums, is taught to owners of dogs with known insulinoma to use during acute hypoglycaemic episodes. This is a temporary measure to stabilise the dog until veterinary care can be accessed, not a substitute for medical treatment.
Cancer Therapy
For dogs with confirmed malignant insulinoma and documented metastatic spread, systemic cancer therapy may be considered as part of the overall management plan.
Chemotherapy protocols for canine insulinoma are less standardised than for some other canine cancers, and response rates are variable. Streptozotocin, a chemotherapy agent with specific toxicity to beta cells, has been used in some cases, though its clinical use in dogs requires careful monitoring for renal toxicity.
Other chemotherapy combinations have been explored in dogs with advanced insulinoma, though evidence for their efficacy remains limited compared to the more extensively studied protocols used in lymphoma or mast cell disease.
The decision to pursue chemotherapy is made in consultation with a veterinary oncologist and should be weighed against the dog’s overall condition, the burden of disease, and the realistic goals of treatment.
Related Products
Prognosis for Dogs with Insulinoma
Prognosis for insulinoma in dogs is variable and depends substantially on the stage of disease at the time of diagnosis and the treatment approach pursued.
For dogs that undergo successful surgical removal of a pancreatic tumor with no confirmed metastasis, median survival times in the range of twelve to eighteen months are reported, with some dogs living considerably longer. Quality of life in this group is often good, particularly in the period immediately following surgery when glucose control is most effective.
For dogs with confirmed metastatic disease at surgery or confirmed spread on pre-operative imaging, the prognosis is more guarded. Debulking surgery combined with medical management can still provide a meaningful period of good quality of life, but long-term disease control is more difficult to achieve.
For dogs managed with medication alone without surgical intervention, median survival is generally shorter, though appropriate medical management can maintain a comfortable quality of life for months in well-managed cases.
The disease is ultimately difficult to cure because microscopic metastasis is so common at the time of diagnosis. The realistic goal for most dogs with insulinoma is a period of well-managed, comfortable life rather than a definitive cure.
That period can be genuinely meaningful. And managing it well, with close veterinary partnership, regular glucose monitoring, dietary discipline, and prompt response to hypoglycaemic episodes, makes a real difference to how that time is experienced.
Monitoring Dogs with Insulinoma
Whether your dog is being managed medically or has undergone surgery, monitoring is an ongoing and active responsibility.
Learn to recognise the early signs of a hypoglycaemic episode: subtle wobbling, a vacant expression, trembling, or sudden weakness. Keep emergency glucose gel or corn syrup accessible at all times. Know your nearest emergency veterinary facility and have their contact number saved.
At home, scheduled small meals should be maintained consistently. Vigorous exercise should be moderated, particularly when blood glucose levels are not well controlled, as physical activity accelerates glucose consumption and can precipitate hypoglycaemia.
Regular veterinary follow-up, including fasting blood glucose checks, insulin measurement where indicated, abdominal ultrasound to monitor for disease progression, and reassessment of medical dosages, is essential to managing this condition safely over time.
Any recurrence of episodic weakness, seizures, or collapse in a dog with known insulinoma should prompt immediate veterinary contact, even if the dog appears to recover quickly on their own.
Can Insulinoma Be Prevented?
No. Insulinoma develops spontaneously from abnormal beta cell proliferation and is not preventable through diet, lifestyle, or any known intervention.
Because the disease arises from a combination of genetic predisposition and the cellular changes of aging, there is no reliable screening test for dogs before symptoms appear, and no proven way to stop the tumor from forming.
What can be done is earlier recognition.
An owner who knows that their large-breed senior dog is in a risk category, who understands what episodic weakness and collapse can mean, and who brings their dog to the vet promptly rather than watching and waiting, is giving their dog the best possible starting point. A diagnosis made before widespread metastasis has occurred gives surgery its best chance of meaningful disease control.
If you have noticed recurring episodes of weakness, trembling, or collapse in your dog and want guidance on next steps, VOSD’s veterinary team can help. For any questions about your dog’s digestive or endocrine health, VOSD’s resources including articles on dog digestive health and gas, osteomyelitis in dogs, and warts in dogs are part of a comprehensive library designed to help you understand your dog’s health from every angle.
